Compare Amphastar Pharmaceuticals Inc (AMPH) vs GE Aerospace (GE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs GE Aerospace — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $863.95M), while GE Aerospace trades at $368.1 (market cap $380.47B). The key difference: GE Aerospace is far larger — about 440.4× Amphastar Pharmaceuticals Inc's market cap, and GE Aerospace pays a 0.51% dividend while Amphastar Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMPH | GE | |
|---|---|---|
Market Cap | $863.95M | $380.47B |
Sector | Health | Industrials |
52-Week High | $30.81 | $381.22 |
52-Week Low | $16.87 | $265.93 |
Enterprise Value | $1.26B | $390.29B |
Dividend Yield | — | 0.51% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $20.78, up 4.9% today, with a bullish technical signal supported by moving averages. The stock shows mixed earnings performance with Q2 2026 beating estimates but Q1 and Q4 2025 missing. Fundamentals remain solid with a 10.76% net margin and reasonable valuation at 12.02 P/E. Recent news highlights Q2 2026 results and strategic shift toward proprietary drugs.
Outlook is cautiously optimistic with growth supported by new product launches, though regulatory risks and earnings volatility pose challenges. Analyst sentiment is mixed with 25% buy ratings but majority hold recommendations. The stock offers value but requires monitoring of FDA developments and earnings consistency.
GE trades at $370.08, down 1.19% today, with a bullish technical signal and strong earnings beats in recent quarters. Revenue grew to $45.86B in 2025, with net income margin at 17.72%, while valuation ratios like P/E of 43.64 appear elevated. Recent news highlights robust aerospace demand and defense contract wins, supporting positive sentiment.
Outlook is favorable due to strong order growth and analyst consensus, but risks include high debt levels and rich valuations. The stock offers upside to the $414.11 price target, yet investors should monitor execution amid competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About GE Aerospace
General Electric Company is a globally diversified technology and financial services company. The Company's products and services include aircraft engines, power generation, water processing, and household appliances to medical imaging, business and consumer financing, and industrial products.
Read more on GE →
